Literature DB >> 19717275

[Could anaesthesia, analgesia and sympathetic modulation affect neoplasic recurrence after surgery? A systematic review centred over the modulation of natural killer cells activity].

P Forget1, M De Kock.   

Abstract

OBJECTIVE: The Natural Killer cells (NK) are an important part of non-specific cellular-mediated and antitumoral immunity. The goal of this review is to recapitulate data published over NK activity during the perioperative period and the influence of anaesthesia, analgesia and modulation of sympathetic system. DATA SOURCES: Pubmed/Medline database. STUDY SELECTION AND DATA EXTRACTION: Keywords-based selection, without limit of date: fundamental studies, randomized controlled trials and non-randomized comparative studies. DATA SYNTHESIS: In human as in animal studies, an important correlation exists between NK activity and prognosis linked to the development of metastasis. The great depression of this cytotoxicity during the perioperative period could be able to compromise host defenses. The influence of anaesthetics and analgesics is important. The effects of the opioids, the agonists and the antagonists of the sympathetic nervous system, the prostaglandins, the NSAIDs, the ketamine, the hypnotics and the locoregional anaesthesia are systematically reviewed. The limits of experimental model presented are covered.
CONCLUSION: The effects of anaesthetic/analgesic drugs and techniques, the consequences of sympathomodulation on NK activity are numerous and sometimes opposite. It is important for the anaesthesiologist to keep in mind that the long term consequences of his techniques on the patients' outcome must be clarified.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717275     DOI: 10.1016/j.annfar.2009.07.078

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  9 in total

Review 1.  [Update on the pharmacology and effects of local anesthetics].

Authors:  J Ahrens; A Leffler
Journal:  Anaesthesist       Date:  2014-05       Impact factor: 1.041

Review 2.  Long-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and Perspectives.

Authors:  Bernhard Riedel; Erica Sloan; Patrice Forget
Journal:  Int Anesthesiol Clin       Date:  2016

Review 3.  The Relationship Between Regional Anesthesia and Cancer: A Metaanalysis.

Authors:  Ravi K Grandhi; Samuel Lee; Alaa Abd-Elsayed
Journal:  Ochsner J       Date:  2017

4.  Morphine use in cancer surgery.

Authors:  Banafsheh Afsharimani; Peter J Cabot; Marie-Odile Parat
Journal:  Front Pharmacol       Date:  2011-08-08       Impact factor: 5.810

5.  Cancer surgery induces inflammation, immunosuppression and neo-angiogenesis, but is it influenced by analgesics?

Authors:  Patrice Forget; Olivier Simonet; Marc De Kock
Journal:  F1000Res       Date:  2013-04-03

Review 6.  Hypnosis in the Perioperative Management of Breast Cancer Surgery: Clinical Benefits and Potential Implications.

Authors:  Arnaud Potié; Fabienne Roelants; Audrey Pospiech; Mona Momeni; Christine Watremez
Journal:  Anesthesiol Res Pract       Date:  2016-08-21

7.  Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial.

Authors:  Patrice Forget; Gauthier Bouche; Francois P Duhoux; Pierre G Coulie; Jan Decloedt; Alain Dekleermaker; Jean-Edouard Guillaume; Marc Ledent; Jean-Pascal Machiels; Véronique Mustin; Walter Swinnen; Aline van Maanen; Lionel Vander Essen; Jean-Christophe Verougstraete; Marc De Kock; Martine Berliere
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

Review 8.  New Insights Into the Pharmacological Management of Postoperative Pain: A Narrative Review.

Authors:  Victor Mayoral Rojals; Moises Charaja; Oscar De Leon Casasola; Antonio Montero; Marco Antonio Narvaez Tamayo; Giustino Varrassi
Journal:  Cureus       Date:  2022-03-10

Review 9.  Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review.

Authors:  Laura Smith; Juan P Cata; Patrice Forget
Journal:  Curr Oncol Rep       Date:  2022-05-28       Impact factor: 5.945

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.